Yuria-Pharm Secures EUR 15M Financing from EBRD

Deal News | Mar 20, 2025 | Asters

Asters, a renowned law firm, recently acted as an advisor to the European Bank for Reconstruction and Development (EBRD) on a significant financial transaction involving a loan of EUR 15 million to Yuria-Pharm. Yuria-Pharm is a prominent Ukrainian pharmaceutical company noted for its substantial influence in the region's healthcare sector. This financing is set against Ukraine’s ongoing need for investment in critical sectors, which is a strategic focus of the EBRD’s investment programs. By securing this loan, Yuria-Pharm is poised to enhance its operational capabilities, strengthen its market presence, and contribute further to the development of the Ukrainian pharmaceutical industry.

Sectors

Pharmaceutical Industry
Financial Services Industry
Legal Advisory Industry

Geography

Ukraine – Yuria-Pharm is a leading Ukrainian pharmaceutical company receiving financing.
European Union – The EBRD, a financial institution with significant interests in the EU, is providing financing.

Industry

Pharmaceutical Industry – Yuria-Pharm operates within the pharmaceutical industry, manufacturing and distributing medical products.
Financial Services Industry – The EBRD’s role as a financial institution providing a loan highlights the financial services industry.
Legal Advisory Industry – Asters provided legal advice to the EBRD, indicating involvement in the legal advisory industry.

Financials

EUR 15 million – The amount of the loan provided by the EBRD to Yuria-Pharm.

Participants

Name	Role	Type	Description
Yuria-Pharm	Target Company	Company	A leading Ukrainian pharmaceutical company receiving a EUR 15 million loan from the EBRD.
European Bank for Reconstruction and Development (EBRD)	Bidding Company/Buyer	Company	An international financial institution investing in projects that promote economic development.
Asters	Legal Advisor	Company	Asters provided legal advisory services to the EBRD for the transaction.